SQI Diagnostics Inc logo

SQI Diagnostics Inc

FRA:XSQ (Canada)  
€ 0.09 (-2.11%) Aug 18
At Loss
Market Cap:
€ 40.71M ($ 44.09M)
Enterprise V:
€ 40.71M ($ 44.09M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for SQI Diagnostics Inc ( ) from 2010 to May 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. SQI Diagnostics stock (FRA:XSQ) PE ratio as of May 23 2024 is 0. More Details

SQI Diagnostics Inc (FRA:XSQ) PE Ratio (TTM) Chart

To

SQI Diagnostics Inc (FRA:XSQ) PE Ratio (TTM) Historical Data

Total 555
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
SQI Diagnostics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-23 At Loss 2021-06-16 At Loss
2021-08-18 At Loss 2021-06-15 At Loss
2021-08-17 At Loss 2021-06-14 At Loss
2021-08-16 At Loss 2021-06-11 At Loss
2021-08-13 At Loss 2021-06-10 At Loss
2021-08-12 At Loss 2021-06-09 At Loss
2021-08-11 At Loss 2021-06-08 At Loss
2021-08-10 At Loss 2021-06-07 At Loss
2021-08-09 At Loss 2021-06-04 At Loss
2021-08-06 At Loss 2021-06-03 At Loss
2021-08-05 At Loss 2021-06-02 At Loss
2021-08-04 At Loss 2021-06-01 At Loss
2021-08-03 At Loss 2021-05-31 At Loss
2021-08-02 At Loss 2021-05-28 At Loss
2021-07-30 At Loss 2021-05-27 At Loss
2021-07-29 At Loss 2021-05-26 At Loss
2021-07-28 At Loss 2021-05-25 At Loss
2021-07-27 At Loss 2021-05-21 At Loss
2021-07-26 At Loss 2021-05-20 At Loss
2021-07-23 At Loss 2021-05-19 At Loss
2021-07-22 At Loss 2021-05-18 At Loss
2021-07-21 At Loss 2021-05-17 At Loss
2021-07-20 At Loss 2021-05-14 At Loss
2021-07-19 At Loss 2021-05-13 At Loss
2021-07-16 At Loss 2021-05-12 At Loss
2021-07-15 At Loss 2021-05-11 At Loss
2021-07-14 At Loss 2021-05-10 At Loss
2021-07-13 At Loss 2021-05-07 At Loss
2021-07-12 At Loss 2021-05-06 At Loss
2021-07-09 At Loss 2021-05-05 At Loss
2021-07-08 At Loss 2021-05-04 At Loss
2021-07-07 At Loss 2021-05-03 At Loss
2021-07-06 At Loss 2021-04-29 At Loss
2021-07-05 At Loss 2021-04-28 At Loss
2021-07-02 At Loss 2021-04-27 At Loss
2021-07-01 At Loss 2021-04-26 At Loss
2021-06-29 At Loss 2021-04-23 At Loss
2021-06-28 At Loss 2021-04-22 At Loss
2021-06-25 At Loss 2021-04-21 At Loss
2021-06-24 At Loss 2021-04-20 At Loss
2021-06-23 At Loss 2021-04-19 At Loss
2021-06-22 At Loss 2021-04-16 At Loss
2021-06-21 At Loss 2021-04-15 At Loss
2021-06-18 At Loss 2021-04-14 At Loss
2021-06-17 At Loss 2021-04-13 At Loss

SQI Diagnostics Inc (FRA:XSQ) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
SQI Diagnostics Inc is the leader in the field of lung health. The company develops and manufactures respiratory health and precision medicine tests that run on SQI's automated systems. The company is developing tests to simplify and improve COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada, and Europe. Canada accounts for more than half of its revenues.